environmental factor - november 2012_ study offers insight into hiv metal and ligand binding

3
7/15/14 2:06 PM Environmental Factor - November 2012: Study offers insight into HIV metal and ligand binding Page 1 of 3 http://www.niehs.nih.gov/news/newsletter/2012/11/science-hiv/index.htm Environmental Factor, November 2012 London’s NMR Group studies the molecular mechanisms that underlie problems of environmental concern. (Photo courtesy of Steve McCaw) Research Fellow Xunhai Zheng, Study offers insight into HIV metal and ligand binding By Cindy Loose A discovery by scientists in the NIEHS Laboratory of Structural Biology (LSB) opens the door for developing new treatments for human immunodeficiency virus (HIV). Members of the LSB Nuclear Magnetic Resonance (NMR) Group, headed by Robert London, Ph.D., identified a new, highly sensitive probe that can monitor the binding of compounds to a viral enzyme that allows HIV to infect humans. The finding is particularly critical, as some patients become resistant to existing antivirals for HIV. “The HIV virus is a moving target, due to its exceptionally high ability to mutate,” London said. “This allows it to escape existing drug therapies. Hence, additional strategies are needed to interfere with the virus.” London and three members of his group published their findings (http://www.ncbi.nlm.nih.gov/pubmed/22941642) online Aug. 31 in the publication Nucleic Acids Research. The critical role of the RNase H domain Understanding the breakthrough requires information about how the virus and current treatments work. HIV is a retrovirus, meaning it stores its genome as RNA instead of DNA, explained staff scientist and paper co-author Geoffrey Mueller, Ph.D. The virus has to convert the single-stranded RNA into double-stranded DNA to infect the host cell. It does so in a three-step process. First, it copies the RNA into DNA creating an RNA:DNA hybrid molecule. Second, it destroys the RNA part of the RNA:DNA hybrid. Third, it copies the remaining single strand of DNA to make double-stranded DNA that eventually infects the host. According to Mueller, most treatments currently available target steps one and three. They do so by interrupting, or inhibiting, the process by which the viral genome is copied. So far, none of the drugs inhibit step two, which is the destruction of the old RNA genome. Mueller believes the new discovery could allow scientists to target this activity, which is carried out by the RNase H domain of the reverse transcriptase enzyme. The RNase H domain is considered equally essential to the replication of the HIV virus as the polymerase domain that is currently targeted by existing treatments.

Upload: xunhai-

Post on 13-Apr-2017

117 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Environmental Factor - November 2012_ Study offers insight into HIV metal and ligand binding

7/15/14 2:06 PMEnvironmental Factor - November 2012: Study offers insight into HIV metal and ligand binding

Page 1 of 3http://www.niehs.nih.gov/news/newsletter/2012/11/science-hiv/index.htm

Environmental Factor, November 2012

London’s NMR Group studiesthe molecular mechanisms thatunderlie problems ofenvironmental concern. (Photocourtesy of Steve McCaw)

Research Fellow Xunhai Zheng,

Study offers insight into HIV metal and ligand bindingBy Cindy Loose

A discovery by scientists in the NIEHS Laboratory of StructuralBiology (LSB) opens the door for developing new treatments forhuman immunodeficiency virus (HIV). Members of the LSB NuclearMagnetic Resonance (NMR) Group, headed by Robert London,Ph.D., identified a new, highly sensitive probe that can monitor thebinding of compounds to a viral enzyme that allows HIV to infecthumans. The finding is particularly critical, as some patients becomeresistant to existing antivirals for HIV.

“The HIV virus is a moving target, due to its exceptionally high abilityto mutate,” London said. “This allows it to escape existing drugtherapies. Hence, additional strategies are needed to interfere withthe virus.”

London and three members of his group published their findings(http://www.ncbi.nlm.nih.gov/pubmed/22941642) online Aug. 31 inthe publication Nucleic Acids Research.

The critical role of the RNase H domain

Understanding the breakthrough requires information about how thevirus and current treatments work. HIV is a retrovirus, meaning itstores its genome as RNA instead of DNA, explained staff scientistand paper co-author Geoffrey Mueller, Ph.D. The virus has toconvert the single-stranded RNA into double-stranded DNA to infectthe host cell. It does so in a three-step process. First, it copies theRNA into DNA creating an RNA:DNA hybrid molecule. Second, itdestroys the RNA part of the RNA:DNA hybrid. Third, it copies theremaining single strand of DNA to make double-stranded DNA thateventually infects the host.

According to Mueller, most treatments currently available targetsteps one and three. They do so by interrupting, or inhibiting, theprocess by which the viral genome is copied. So far, none of thedrugs inhibit step two, which is the destruction of the old RNAgenome. Mueller believes the new discovery could allow scientists totarget this activity, which is carried out by the RNase H domain of thereverse transcriptase enzyme. The RNase H domain is consideredequally essential to the replication of the HIV virus as the polymerasedomain that is currently targeted by existing treatments.

Page 2: Environmental Factor - November 2012_ Study offers insight into HIV metal and ligand binding

7/15/14 2:06 PMEnvironmental Factor - November 2012: Study offers insight into HIV metal and ligand binding

Page 2 of 3http://www.niehs.nih.gov/news/newsletter/2012/11/science-hiv/index.htm

Research Fellow Xunhai Zheng,Ph.D., is first author on thepaper. (Photo courtesy of SteveMcCaw)

Eugene DeRose, Ph.D., is a co-author and serves as NMR Mueller was instrumental is

NMR

The new probe identified by London and colleagues can monitor thebinding of compounds to the RNase H domain. They found that oneof the residues of the protein had a characteristic signature whencompounds bound, despite the residue being very distant from the active site. Using NuclearMagnetic Resonance (NMR) spectroscopy, they realized that the residue is a good probe of what’sin the active site. Their results will allow scientists who are testing a treatment intended to inhibitthe HIV virus to see whether or not the potential drug is binding to the RNase H domain and havingan effect.

NMR is a research technique that exploits the magnetic properties of atomic nuclei to studymolecules. It can provide detailed information about the structure, dynamics, chemicalenvironment, and even the reactions of molecules.

“There had been attempts to identify inhibitors of RNase H activity, but because it has such astrange active site, the work has been difficult,” said Mueller. “This finding advances the goal offinding an antiviral that works on this domain.”

The group plans to continue work on understanding the RNase H domain and its promise as adrug target.

Citation: Zheng X, Mueller GA, DeRose EF, London RE.(http://www.ncbi.nlm.nih.gov/pubmed/22941642) 2012. Metal and ligand binding to the HIV-RNaseH active site are remotely monitored by Ile556. Nucleic Acids Res; doi:10.1093/nar/gks791 [Online31 August 2012].

(Cindy Loose is a contract writer with the NIEHS office in Bethesda, Md.)

Page 3: Environmental Factor - November 2012_ Study offers insight into HIV metal and ligand binding

7/15/14 2:06 PMEnvironmental Factor - November 2012: Study offers insight into HIV metal and ligand binding

Page 3 of 3http://www.niehs.nih.gov/news/newsletter/2012/11/science-hiv/index.htm

Center Manager. (Photocourtesy of Steve McCaw)

Mueller was instrumental isexplaining the science for thisEnvironmental Factor article.(Photo courtesy of SteveMcCaw)

The Environmental Factor is produced monthly by the National Institute of Environmental Health Sciences (NIEHS)(http://www.niehs.nih.gov/), Office of Communications and Public Liaison. The content is not copyrighted, and it can bereprinted without permission. If you use parts of Environmental Factor in your publication, we ask that you provide us witha copy for our records. We welcome your comments and suggestions. ([email protected])

This page URL: http://www.niehs.nih.gov/news/newsletter/2012/11/science-hiv //Sites/NIEHS_eFactor/NIEHS website: http://www.niehs.nih.gov/Email the Web Manager at [email protected]